The company had posted a net profit of Rs 92.71 crore for the corresponding period of the previous fiscal, Eris Lifesciences said in a BSE filing.
PTI
Drug firm Eris Lifesciences on November 3 reported a 16.19 percent rise in its consolidated net profit to Rs 107.72 crore for the quarter ended September mainly on account of robust sales.
The company had posted a net profit of Rs 92.71 crore for the corresponding period of the previous fiscal, Eris Lifesciences said in a BSE filing.
Total revenue from operations stood at Rs 329.99 crore for the quarter under consideration. It was Rs 284.79 crore for the same period year ago, it added.
Shares of Eris Lifesciences were trading at Rs518.35 per scrip on BSE, up 1.45 percent over previous close.First Published on Nov 3, 2020 07:44 pm